For months, various newspapers have been trying to associate Donald Trump and his administration with Ayn Rand and her philosophy. Learn Liberty just published Steve Simpson’s all-new essay titled “Crony-In-Chief: Donald Trump Epitomizes Ayn Rand's ‘Aristocracy of Pull,’” in which he not only sets the record straight, but he also offers a radical solution to “cronyism.”
Recently, I debated Professor Rick L. Hasen of UC Irvine School of Law at a Federalist Society event at Southwestern School of Law in LA. The subject was campaign finance law, and Professor Hasen took the opportunity to outline the case he makes in his new book, Plutocrats United: Campaign Money, the Supreme Court, and the Distortion of American Elections. From the title, you might guess that he is both not a fan of the Supreme Court’s Citizens United decision and that he thinks money in politics is leading to a kind of plutocracy, in which the wealthy end up influencing government far out of proportion to everyone else.
Stories about government officials getting perks from those with business before them aren’t exactly rare today. Remember those amazing loan deals Senator Chris Dodd received from Countrywide Bank while he was the Chairman of the Senate Banking Committee? Or the millions in donations made to the Clinton Foundation by foreign governments and companies that stood to benefit from arms deals with the U.S. while Hillary was Secretary of State?
I had a strong sense of déjà vu when I read this Wall Street Journal editorial about Argentina’s harassment of a U.S. printing company for closing a plant in Buenos Aires. Why did this sound so familiar?
The American Enterprise Institute recently published a paper, authored by eight economists, detailing the alternative health care system they prefer to Obamacare. I disagree with much of what they have to say, but I want to focus here on one crucial problem: The paper tries to achieve the impossible.
A recent NPR story described efforts to extend the Genetic Information Nondiscrimination Act (GINA) to long-term care insurance providers. GINA, passed in 2008, prohibits health insurers from taking into account genetic information about you when deciding what coverage to offer you and at what price.